Similar patterns of chromosome abnormalities in CML occur in addition to the Philadelphia chromosome with or without tyrosine kinase inhibitor treatment
Open Access
- 29 October 2009
- journal article
- letter
- Published by Springer Nature in Leukemia
- Vol. 24 (3) , 638-640
- https://doi.org/10.1038/leu.2009.222
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Cytogenetic evolution patterns in CML post-SCTBone Marrow Transplantation, 2007
- CyDAS: a cytogenetic data analysis systemBioinformatics, 2004
- Clonal evolution in chronic myelogenous leukemiaHematology/Oncology Clinics of North America, 2004
- Clonal evolution and lack of cytogenetic response are adverse prognostic factors for hematologic relapse of chronic phase CML patients treated with imatinib mesylateBlood, 2004
- Prognostic significance of cytogenetic clonal evolution in patients with chronic myelogenous leukemia on imatinib mesylate therapyBlood, 2003
- The impact of clonal evolution on response to imatinib mesylate (STI571) in accelerated phase CMLBlood, 2002
- Cytogenetic and Molecular Genetic Evolution of Chronic Myeloid LeukemiaActa Haematologica, 2002
- Non-random involvement of chromosome 13 in patients with persistent or relapsed disease after bone-marrow transplantation for chronic myeloid leukemiaGenes, Chromosomes and Cancer, 2000